(1)
Rayamajhi, A.; Acharya, B.; Khanal, B. TP53 Mutation As Molecular Marker in the Assessment of Surgical Margin Status in Head and Neck Squamous Cell Carcinoma. Nep. J. Cancer 2021, 5, 27-32.